Zimmer Biomet has gained 510(k) clearance from the US Food and Drug Administration (FDA) for the OsseoFit Stemless Shoulder System. Designed for total shoulder replacement, the implant is tailored ...

Zimmer Biomet Holdings Inc (NYSE:ZBH), a leading player in the medical devices sector with a market capitalization of $22.12 ...

Last month, Zimmer Biomet received 510(k) clearance from the US Food and Drug Administration for its OsseoFit Stemless Shoulder System. "Zimmer Biomet agrees to acquire Paragon 28 for $1.2bn" was ...

In orthopedic surgery, robotic-assisted implant procedures are expected to grow in the coming year, with Stryker and Zimmer ...

Medical device maker Zimmer Biomet Holdings forecast full-year adjusted profit below Wall Street estimates on Thursday, as it ...

Zimmer Biomet made a major play in the foot and ankle treatment space today, announcing it will spend $1.2 billion to acquire ...

Zimmer Biomet Holdings, Inc. ZBH is scheduled to ... The recent FDA approval of OsseoFit Stemless Shoulder System for total shoulder replacement is expected to have contributed to the fourth ...